155 related articles for article (PubMed ID: 28260052)
1. LMTK3 knockdown retards cell growth and invasion and promotes apoptosis in thyroid cancer.
Lu L; Yuan X; Zhang Q; Zhang H; Shen B
Mol Med Rep; 2017 Apr; 15(4):2015-2022. PubMed ID: 28260052
[TBL] [Abstract][Full Text] [Related]
2. Effect of ABCE1-silencing gene, transfected by electrotransfer, on the proliferation, invasion, and migration of human thyroid carcinoma SW579 cells.
Qu X; Zhang L
Genet Mol Res; 2015 Nov; 14(4):14680-9. PubMed ID: 26600528
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA H19 Inhibits Cell Viability, Migration, and Invasion Via Downregulation of IRS-1 in Thyroid Cancer Cells.
Wang P; Liu G; Xu W; Liu H; Bu Q; Sun D
Technol Cancer Res Treat; 2017 Dec; 16(6):1102-1112. PubMed ID: 29332545
[TBL] [Abstract][Full Text] [Related]
4. LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway.
Jiang T; Lu X; Yang F; Wang M; Yang H; Xing N
FEBS Open Bio; 2020 Oct; 10(10):2107-2121. PubMed ID: 32865871
[TBL] [Abstract][Full Text] [Related]
5. MiR-223 inhibitor suppresses proliferation and induces apoptosis of thyroid cancer cells by down-regulating aquaporin-1.
Zhang Q; Lin L; Li W; Lu G; Li X
J Recept Signal Transduct Res; 2019 Apr; 39(2):146-153. PubMed ID: 31311397
[TBL] [Abstract][Full Text] [Related]
6. Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression.
Zhang K; Chen L; Deng H; Zou Y; Liu J; Shi H; Xu B; Lu M; Li C; Jiang J; Wang Z
Int J Clin Exp Pathol; 2015; 8(1):629-35. PubMed ID: 25755755
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Tyrosine Kinase FYN in Human Thyroid Carcinoma: Role in Modulating Tumor Cell Proliferation, Invasion, and Migration.
Zheng J; Li H; Xu D; Zhu H
Cancer Biother Radiopharm; 2017 Nov; 32(9):320-326. PubMed ID: 29140740
[TBL] [Abstract][Full Text] [Related]
8. Lemur tyrosine kinase-3 is a significant prognostic marker for patients with colorectal cancer.
Shi H; Li Q; Ji M; Wu J; Li Z; Zheng X; Xu B; Chen L; Li X; Lu C; Tan Y; Wu C; Jiang J
Int J Clin Exp Pathol; 2014; 7(3):1101-7. PubMed ID: 24695631
[TBL] [Abstract][Full Text] [Related]
9. KLF5 promotes the tumorigenesis and metastatic potential of thyroid cancer cells through the NF-κB signaling pathway.
Ma Y; Wang Q; Liu F; Ma X; Wu L; Guo F; Zhao S; Huang F; Qin G
Oncol Rep; 2018 Nov; 40(5):2608-2618. PubMed ID: 30226614
[TBL] [Abstract][Full Text] [Related]
10. Oleanolic acid inhibits cell proliferation migration and invasion and induces SW579 thyroid cancer cell line apoptosis by targeting forkhead transcription factor A.
Duan L; Yang Z; Jiang X; Zhang J; Guo X
Anticancer Drugs; 2019 Sep; 30(8):812-820. PubMed ID: 30882397
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum LMTK3 as a novel biomarker in non-small cell lung cancer.
Xu Z; Qi X; Zhang X; Yu L
Tumour Biol; 2014 May; 35(5):5007-11. PubMed ID: 24510346
[TBL] [Abstract][Full Text] [Related]
12. [Effects of serine/threonine-protein kinase B-Raf-activated long-chain non-coding RNA on apoptosis and autophagy in thyroid carcinoma cells].
Liu T; Zhao Y; Wang L; Jia H; Cui D; Si Y; Wang H; Xue H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):747-753. PubMed ID: 30124210
[TBL] [Abstract][Full Text] [Related]
13. Downregulated LRRK2 gene expression inhibits proliferation and migration while promoting the apoptosis of thyroid cancer cells by inhibiting activation of the JNK signaling pathway.
Jiang ZC; Chen XJ; Zhou Q; Gong XH; Chen X; Wu WJ
Int J Oncol; 2019 Jul; 55(1):21-34. PubMed ID: 31180559
[TBL] [Abstract][Full Text] [Related]
14. High expression of LMTK3 is an independent factor indicating a poor prognosis in estrogen receptor α-positive breast cancer patients.
Asano T; Sato S; Yoshimoto N; Endo Y; Hato Y; Dong Y; Takahashi S; Fujii Y; Toyama T
Jpn J Clin Oncol; 2014 Oct; 44(10):889-97. PubMed ID: 25163465
[TBL] [Abstract][Full Text] [Related]
15. IL-17RB enhances thyroid cancer cell invasion and metastasis via ERK1/2 pathway-mediated MMP-9 expression.
Ren L; Xu Y; Liu C; Wang S; Qin G
Mol Immunol; 2017 Oct; 90():126-135. PubMed ID: 28715683
[TBL] [Abstract][Full Text] [Related]
16. LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5.
Jacob J; Favicchio R; Karimian N; Mehrabi M; Harding V; Castellano L; Stebbing J; Giamas G
Cancer Lett; 2016 Mar; 372(1):137-46. PubMed ID: 26739063
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) on Thyroid Carcinoma.
Li HG; Zhao LH; Zhang ZH; Liu JZ; Ren K; Li SY; Su ZJ
Cell Physiol Biochem; 2017; 43(5):2037-2046. PubMed ID: 29059670
[TBL] [Abstract][Full Text] [Related]
18. The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion.
Zhong J; Liu C; Chen YJ; Zhang QH; Yang J; Kang X; Chen SR; Wen GB; Zu XY; Cao RX
J Transl Med; 2016 Mar; 14():80. PubMed ID: 27008379
[TBL] [Abstract][Full Text] [Related]
19. HOXC10 up-regulation contributes to human thyroid cancer and indicates poor survival outcome.
Feng X; Li T; Liu Z; Shi Y; Peng Y
Mol Biosyst; 2015 Nov; 11(11):2946-54. PubMed ID: 26279264
[TBL] [Abstract][Full Text] [Related]
20. Lemur tyrosine kinase-3 (LMTK3) induces chemoresistance to cetuximab in colorectal cancer via the ERK/MAPK pathway.
Wang C; Yang M; Gu X; Gu Y
Bioengineered; 2021 Dec; 12(1):6594-6605. PubMed ID: 34516351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
